• Nie Znaleziono Wyników

Letter to the Editor<br>

N/A
N/A
Protected

Academic year: 2022

Share "Letter to the Editor<br>"

Copied!
1
0
0

Pełen tekst

(1)

Postępy w Kardiologii Interwencyjnej 2012; 8, 4 (30)

365 Letter to the Editor/List do Redakcji

DOI: 10.5114/pwki.2012.31924

Dear Editor,

We read the article “Paraoxonase-1 activity and the lev- els of lipids and lipid peroxidation markers in arterial ver- sus venous blood samples in coronary angiography patients” written by Göçmen et al. with great interest [1].

The authors aimed to explore whether arterial blood sam- ples withdrawn from femoral arteries can be used to deter- mine some biochemical parameters.

Coronary artery disease (CAD) is the leading cause of death worldwide [2]. Oxidized low-density lipoprotein (ox-LDL) is accepted to be a key factor of initiating and accelerating atherosclerosis. High-density lipoprotein-asso- ciated proteins like paraoxonase 1 (PON1) enzyme prevent lipid oxidation. Paraoxonase 1 hydrolyzes lipid peroxides in atherosclerotic lesions, where they promote progression of atherogenesis. Coronary artery disease is associated with decreased plasma PON1 activity [3]. Göçmen et al. [1]

showed that arterial blood samples can also be used to determine these parameters as well as venous samples.

This is an interesting study. On the other hand, we would like to make a minor criticism about the methodological aspect.

Blood samples were withdrawn at 8 am, after 12 h of fasting, from the femoral artery and vena mediana cubiti at the same time. However, it is impossible to perform all the coronary angiographies at the same time. It would be better if the authors explained this issue.

R

Reeffeerreenncceess

1. Göçmen AY, Gűműșlű S, Gűnaydin I, Semiz E. Paraoxonase-1 activ- ity and the levels of lipids and lipid peroxidation markers in arte- rial versus venous blood samples in coronary angiography patients.

Postep Kardiol Inter 2012; 8: 199-204.

2. Zalewski J, Nycz K, Przewłocki T, et al. Conservative strategy in patients with non-ST-segment elevation acute coronary syndromes Postep Kardiol Inter 2010; 6: 147-153.

3. Sesal C, Ciloglu F, Peker I, Sayar N. Role of angiotensin converting enzyme, paraoxonase 155, 192 gene polymorphisms in syndrome X and coronary heart disease. Pak J Biol Sci 2009; 12: 46-51.

A

Assssiisstt.. PPrrooff.. SSaaiitt DDeemmiirrkkooll MMDD Department of Cardiology Gulhane School of Medicine Tevfik Saglam St 06018 Etlik-Ankara, Turkey tel.: +90 312 3044281 fax: +90-312-3044250 e-mail: saitdemirkol@yahoo.com M

Muussttaaffaa CCaakkaarr SSeevvkkeett BBaallttaa Department of Internal Medicine ZZeekkeerriiyyaa AArrssllaann School of Medicine MMuurraatt UUnnlluu Gulhane Military Medical Academy UUgguurr KKuuccuukk Ankara, Turkey Department of Cardiology School of Medicine Gulhane Military Medical Academy Ankara, Turkey

DOI: 10.5114/pwki.2012.31925

Dear Sir,

On behalf of the author group, we would hereby like to thank Demirkol et al. for their valuable comments. In our previous study [1], we reported the relationship among various risk factors evaluated in venous blood samples of study participants who underwent coronary angiogra- phy for the presence of coronary artery disease (CAD). In this study [2] our aim was to determine whether arterial blood samples withdrawn from femoral arteries during standard Judkin’s technique could be used for the evalu- ation of some biochemical parameters in CAD patients and controls. For practical reasons, the fasting blood samples of 73 CAD patients and 50 controls were obtained just before coronary angiography starting from 8 o’clock in the morning. Attention was paid to collecting arterial and venous blood samples of each person at the same time in the morning after a 12 h fast.

R

Reeffeerreenncceess

1. Gocmen YA, Semiz E, Gumuslu S. Relationship between para - oxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region. Eur J Cardiovasc Prev Rehabil 2005; 12: 185-186.

2. Göçmen AY, Gűműșlű S, Gűnaydin I.

, Semiz E. Paraoxonase-1 acti - vity and the levels of lipids and lipid peroxidation markers in arterial versus venous blood samples in coronary angiography patients. Postep Kardiol Inter 2012; 8: 199-204.

A

Ayyșșee YYeeșșiimm Göççmmeenn Department of Biochemistry

Faculty of Medicine Bozok University Yozgat, Turkey P

Prrooff.. DDrr.. SSaaaaddeett Gümüșșllüü PPhhDD Department of Biochemistry Faculty of Medicine Akdeniz University 07070 Antalya, Turkey tel.: + 90 242 2496896 fax:+ 90 242 2274495, 2274482 e-mail: sgumuslu@akdeniz.edu.tr E

Ennddeerr SSeemmiizz II..

llhhaann Günnaayyddiinn Department of Cardiology Department of Internal Medicine

Faculty of Medicine Faculty of Medicine

Pamukkale University Bozok University

Denizli, Turkey Yozgat, Turkey

Cytaty

Powiązane dokumenty

Gratulujàc Autorom interesujàcego opisu ciekawego i rzadkiego nowotworu trzustki, nale˝y wyraziç ˝al, ˝e nie odnaleêli oni przypadków tego nowotworu, opisywanych w

Celem pracy była ocena wpływu środka kontra- stowego stosowanego podczas koronarografii na stę- żenia kreatyniny i dwóch wybranych parametrów funkcji śródbłonka,

They have asked if we consider that the elevated levels of mean platelet volume (MPV) and total white blood cell (WBC) count predict cardiovascular events in acute coronary

The circadian periodicity may influence the cardiovas- cular system physiology including the blood pressure, heart rate, cardiac output and endothelial function in fasting patients

Paraoxonase-1 activity and the levels of lipids and lipid peroxidation markers in arterial versus venous blood samples in coronary angiography patients.. Aktywność paraoksonazy

Zabiegi cewnikowania przez nak³ucie têtnicy promieniowej u ludzi w podesz³ym wieku s¹ bezpieczne i w porównaniu z nak³uciem têtnicy udowej wi¹¿¹ siê z o wiele

Niepoprawny jest też zwrot stosowanie preparatów kwasu acetylosalicylowego zamiast stosowanie kwasu acetylosalicylowego, tym bardziej że słowo preparat raczej odnosi się do

Purpose: Catalase (cat) and glutathione peroxidase (GSH-Px) activities and thiobarbituric acid reactive substances (TBARS) con- centration in blood platelets were determined in